CIBC Private Wealth Group’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-254
Closed -$23.2K 3084
2025
Q1
$23.2K Buy
254
+154
+154% +$14.2K ﹤0.01% 1937
2024
Q4
$9.22K Hold
100
﹤0.01% 2293
2024
Q3
$9.65K Hold
100
﹤0.01% 2415
2024
Q2
$9.72K Hold
100
﹤0.01% 2305
2024
Q1
$9.24K Buy
+100
New +$9.37K ﹤0.01% 2307

Other funds holding AMED

CIBC Private Wealth Group's AMED Position: Q2 2025 in Review

CIBC Private Wealth Group sold out of Amedisys (AMED) in Q2 2025, closing a stake of 254 shares — an estimated $23.2K sold.

CIBC Private Wealth Group first reported a position in AMED in Q1 2024 and held it in 5 quarters. The position peaked at $23.2K in Q1 2025. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • CIBC Private Wealth Group reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 254 Amedisys shares in Q2 2025, an estimated $23.2K.
  • CIBC Private Wealth Group first reported a position in Amedisys in Q1 2024 and held it in 5 quarters.
  • CIBC Private Wealth Group's Amedisys position peaked at $23.2K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on CIBC Private Wealth Group's 13F filing for Q2 2025, filed 12 Aug 2025.